CN109890394A - 作为子宫内膜异位症的生物标志物的微小rna - Google Patents

作为子宫内膜异位症的生物标志物的微小rna Download PDF

Info

Publication number
CN109890394A
CN109890394A CN201780066779.9A CN201780066779A CN109890394A CN 109890394 A CN109890394 A CN 109890394A CN 201780066779 A CN201780066779 A CN 201780066779A CN 109890394 A CN109890394 A CN 109890394A
Authority
CN
China
Prior art keywords
mir
mirna
endometriosis
subject
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780066779.9A
Other languages
English (en)
Chinese (zh)
Inventor
休·泰勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of CN109890394A publication Critical patent/CN109890394A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
CN201780066779.9A 2016-08-30 2017-08-30 作为子宫内膜异位症的生物标志物的微小rna Pending CN109890394A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662381130P 2016-08-30 2016-08-30
US62/381,130 2016-08-30
PCT/US2017/049284 WO2018044979A1 (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis

Publications (1)

Publication Number Publication Date
CN109890394A true CN109890394A (zh) 2019-06-14

Family

ID=61301726

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780066779.9A Pending CN109890394A (zh) 2016-08-30 2017-08-30 作为子宫内膜异位症的生物标志物的微小rna

Country Status (11)

Country Link
US (3) US10982282B2 (https=)
EP (1) EP3506912B1 (https=)
JP (2) JP2019528081A (https=)
KR (1) KR20190057305A (https=)
CN (1) CN109890394A (https=)
AU (1) AU2017319325A1 (https=)
BR (1) BR112019004075A2 (https=)
CA (1) CA3035429A1 (https=)
MX (1) MX2019002425A (https=)
SG (2) SG11201901834WA (https=)
WO (1) WO2018044979A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111295453A (zh) * 2017-08-30 2020-06-16 圆点实验室公司 用于检测和治疗子宫内膜异位症的方法和组合物
CN111909997A (zh) * 2020-09-09 2020-11-10 上海交通大学 miRNA标志物在制备奥氮平治疗精神分裂症疗效评估方面的产品中的应用及试剂盒
CN114144674A (zh) * 2019-07-22 2022-03-04 豪夫迈·罗氏有限公司 P物质作为用于子宫内膜异位症的非侵入性诊断的血液生物标志物

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3800267A1 (en) 2014-03-27 2021-04-07 Yale University Circulating micrornas as biomarkers for endometriosis
MX2019002425A (es) 2016-08-30 2019-08-16 Univ Yale Micro ácidos ribonucleicos como biomarcadores para la endometriosis.
US12286629B2 (en) 2018-07-13 2025-04-29 Yale University Compositions and methods for treating endometriosis
KR102089559B1 (ko) 2018-08-31 2020-03-16 차의과학대학교 산학협력단 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도
WO2020092672A2 (en) * 2018-10-31 2020-05-07 Yale University A quantitative algorithm for endometriosis
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
WO2020146544A1 (en) * 2019-01-09 2020-07-16 Research Institute At Nationwide Children's Hospital A novel method for monitoring endometriosis and associated disorders
WO2020179895A1 (ja) 2019-03-07 2020-09-10 東レ株式会社 子宮平滑筋肉腫の検出のためのキット、デバイス及び方法
ES2787725A1 (es) * 2019-04-15 2020-10-16 Univ Granada Metodo de obtencion de datos utiles para diagnosticar telangiectasia hemorragica hereditaria
CN110144394A (zh) * 2019-04-18 2019-08-20 辽宁省肿瘤医院 一种子宫内膜异位症诊断、预后标志物及其应用
WO2021013785A1 (en) * 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a9 as blood biomarker for the non-invasive diagnosis of endometriosis
EP4004553A1 (en) * 2019-07-22 2022-06-01 F. Hoffmann-La Roche AG S100a8 as blood biomarker for the non-invasive diagnosis of endometriosis
US11965879B2 (en) 2019-08-23 2024-04-23 Mcmaster University Method for diagnosing and assessing endometriosis
KR102242639B1 (ko) * 2020-01-28 2021-04-21 고려대학교 산학협력단 간 섬유화 진단용 바이오마커 miRNA4668-5p
KR102316507B1 (ko) * 2020-02-28 2021-10-22 차의과학대학교 산학협력단 난소 예비력 바이오마커 및 이의 용도
JP2022063860A (ja) * 2020-10-12 2022-04-22 学校法人近畿大学 ホウ素化合物およびその製造方法
KR102940037B1 (ko) * 2022-12-06 2026-03-16 연세대학교 산학협력단 자궁내막증 진단용 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103237901A (zh) * 2010-03-01 2013-08-07 卡里斯生命科学卢森堡控股有限责任公司 用于治疗诊断的生物标志物
US20140024590A1 (en) * 2011-02-18 2014-01-23 Yale University KRAS-Variant And Endometriosis
WO2015128671A1 (en) * 2014-02-27 2015-09-03 Queen Mary University Of London Biomarkers for endometriosis
EP2924126A1 (en) * 2014-03-28 2015-09-30 Reproduktiivmeditsiini TAK AS Method for using microRNA (miRNA) for detection of endometriosis
WO2015148919A2 (en) * 2014-03-27 2015-10-01 Yale University Circulating micrornas as biomarkers for endometriosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317820A1 (en) 2008-05-19 2009-12-24 The Regents Of The University Of California Micro-rna profile in human saliva and its use for detection of oral cancer
WO2010056337A2 (en) 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
CA2757517A1 (en) 2009-04-07 2010-10-21 Velin-Pharma A/S Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
CA2825522A1 (en) * 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
FR2984358A1 (fr) 2011-12-16 2013-06-21 Genethon Methodes pour le diagnostic de dystrophies musculaires
WO2013148151A1 (en) 2012-03-29 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
US10927412B2 (en) 2013-10-01 2021-02-23 The Regents Of The University Of California Endometriosis classifier
CN105917005B (zh) * 2013-11-18 2020-09-11 迪阿米尔有限责任公司 使用来自体液的miRNA检测和监控帕金森病(PD)的方法
US9650676B2 (en) 2014-03-19 2017-05-16 University Of South Carolina Leukocyte MicroRNAS for use in diagnosis and treatment of endometriosis
GB201603967D0 (en) * 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
MX2019002425A (es) 2016-08-30 2019-08-16 Univ Yale Micro ácidos ribonucleicos como biomarcadores para la endometriosis.
WO2019046494A1 (en) 2017-08-30 2019-03-07 Dot Laboratories, Inc. METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF ENDOMETRIOSIS
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
WO2020092672A2 (en) 2018-10-31 2020-05-07 Yale University A quantitative algorithm for endometriosis
BR112021021866A2 (pt) 2019-04-29 2021-12-21 Dot Laboraties Inc Classificadores para a detecção de endometriose

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103237901A (zh) * 2010-03-01 2013-08-07 卡里斯生命科学卢森堡控股有限责任公司 用于治疗诊断的生物标志物
US20140024590A1 (en) * 2011-02-18 2014-01-23 Yale University KRAS-Variant And Endometriosis
WO2015128671A1 (en) * 2014-02-27 2015-09-03 Queen Mary University Of London Biomarkers for endometriosis
WO2015148919A2 (en) * 2014-03-27 2015-10-01 Yale University Circulating micrornas as biomarkers for endometriosis
EP2924126A1 (en) * 2014-03-28 2015-09-30 Reproduktiivmeditsiini TAK AS Method for using microRNA (miRNA) for detection of endometriosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
COSAR E ET AL: "Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis", 《FERTILITY AND STERILITY》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111295453A (zh) * 2017-08-30 2020-06-16 圆点实验室公司 用于检测和治疗子宫内膜异位症的方法和组合物
CN114144674A (zh) * 2019-07-22 2022-03-04 豪夫迈·罗氏有限公司 P物质作为用于子宫内膜异位症的非侵入性诊断的血液生物标志物
CN111909997A (zh) * 2020-09-09 2020-11-10 上海交通大学 miRNA标志物在制备奥氮平治疗精神分裂症疗效评估方面的产品中的应用及试剂盒
WO2022052678A1 (zh) * 2020-09-09 2022-03-17 上海交通大学 miRNA标志物在制备奥氮平治疗精神分裂症疗效评估方面的产品中的应用及试剂盒
US12146192B2 (en) 2020-09-09 2024-11-19 Shanghai Jiao Tong University Use of microRNA (miRNA) marker in preparation of product for evaluating therapeutic effect of olanzapine in treatment of schizophrenia (SZ) and kit

Also Published As

Publication number Publication date
EP3506912B1 (en) 2024-04-03
US20190276893A1 (en) 2019-09-12
US11220713B2 (en) 2022-01-11
US20220049312A1 (en) 2022-02-17
MX2019002425A (es) 2019-08-16
JP2022188086A (ja) 2022-12-20
SG11201901834WA (en) 2019-03-28
KR20190057305A (ko) 2019-05-28
JP2019528081A (ja) 2019-10-10
US12077803B2 (en) 2024-09-03
SG10202102509TA (en) 2021-04-29
WO2018044979A1 (en) 2018-03-08
BR112019004075A2 (pt) 2019-05-28
AU2017319325A1 (en) 2019-03-21
EP3506912A1 (en) 2019-07-10
US10982282B2 (en) 2021-04-20
EP3506912A4 (en) 2020-08-19
US20210180134A1 (en) 2021-06-17
CA3035429A1 (en) 2018-03-08

Similar Documents

Publication Publication Date Title
CN109890394A (zh) 作为子宫内膜异位症的生物标志物的微小rna
JP6755391B2 (ja) 胃癌の生物学的特性に基づく群区分および予後予測システム
US11993816B2 (en) Circulating microRNA as biomarkers for endometriosis
JP2004535771A (ja) Ｅｒｃｃ１及びｔｓ発現に基づく化学療法剤投与計画の決定方法
WO2016186987A1 (en) Biomarker micrornas and method for determining tumor burden
AU2018202963A1 (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
US20190316207A1 (en) Mir-320e and colorectal cancer
EP3873487A2 (en) A quantitative algorithm for endometriosis
Andreasen Molecular features of adenoid cystic carcinoma with an emphasis on microRNA expression.
CN109182521A (zh) circRNA作为甲状腺乳头状癌标志物的应用
CN109055555A (zh) 一种肺癌早期转移诊断标志物及其试剂盒和应用
CN107519193A (zh) 食管鳞癌早期分子诊断标志物及其应用
EP3321377B1 (en) Method for determining sensitivity to simultaneous inhibitor against parp and tankyrase
WO2018095933A1 (en) Method of prognosticating, or for determining the efficiency of a compound for treating cancer
CN105441405B (zh) Bmx剪切体及其在肺癌耐药性中的应用
RU2451937C2 (ru) Способ диагностики рака молочной железы по уровню рнк интерлейкинов il-8 и/или il-18 в плазме крови
CN107365859B (zh) LncRNA作为诊治骨肉瘤的分子标志物
CN110777206B (zh) Loc90024 rna的应用及诊断、预后评估和治疗肿瘤的产品
HK40049419A (en) Circulating micrornas as biomarkers for endometriosis
CN106148561A (zh) 前列腺癌的诊疗标记物
CN107058499A (zh) 一种用于肺腺癌诊治的分子标志物
CN119842905A (zh) 一种与膀胱癌相关的生物标志物及其应用
Hiew The Prognostic Potential of the Long Non-Coding RNA MALAT1 and LDH Related Metabolism in Prostate Cancer
HK40011172A (en) Micrornas as biomarkers for endometriosis
HK40011172B (en) Micrornas as biomarkers for endometriosis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190614